Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-19-011924

President and CEO acquired 169,032 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Leuthner Brian A President and CEO 2019-03-15 Option exercise +169,032 239,268 D
Derivatives
Leuthner Brian A President and CEO 2019-03-15 Option exercise · Restricted Stock Units −169,032 0 D
Loading xslF345X03/form4.xml…